Panbela Therapeutics, Inc.

. As previously disclosed in the Prior 8-K, the proceeds from the sale of the Notes will be used for the Company’s general corporate purposes and to repay certa

. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The disclosure under Item 1.01 of this Curr

. Unregistered Sales of Equity Securities. The Notes were issued in reliance on the exemption from registration set forth in Section 4(a)(2) of the Securities A

. Changes in Control of Registrant. The disclosure under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. No shares of the Comp

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Senior Convertible Promissory Tranche B Note issued to Nant Capital, LLC, dated No